Total raised
$1.3M
Last: Undisclosed 2025-04
Stage
Seed
Founded
2023
Headcount
5
HQ
Or Yehuda
Sector
Health Tech & Life Sciences
About
LifeCord develops a Transfemoral Mitral Chordal Repair system, addressing the significant challenge of mitral regurgitation.
Funding history · 2 rounds · $1.3M total
2025-04
Undisclosed
Undisclosed
2024-04
Seed
$1.3M
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is LifeCord's primary focus?
- LifeCord develops a Transfemoral Mitral Chordal Repair system, designed to address mitral regurgitation.
- When was LifeCord founded?
- LifeCord was founded in September 2023.
- How much funding has LifeCord raised in total?
- LifeCord has raised a total of $1,300,000 USD.
- When did LifeCord secure its Seed funding round?
- In April 2024, LifeCord closed a Seed round with investors including Israel Innovation Authority and MEDX Xelerator.
- Which investor participated in LifeCord's undisclosed funding round in April 2025?
- Edge Medical Ventures was a lead investor in LifeCord's undisclosed funding round in April 2025.
- What is the current employee count for LifeCord?
- LifeCord currently has 5 employees.
- What is LifeCord's current product stage?
- LifeCord's product is currently in the R&D stage.
- What is the primary sector for LifeCord?
- LifeCord's primary sector is Health Tech & Life Sciences.
- What was a notable news item for LifeCord in November 2024?
- On November 19, 2024, CTech reported on LifeCord's mitral chordal repair solution as an alternative to open-heart surgery.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2C
Tags
healthcarecardiologyheart-diseasessurgery-toolssurgery